30433-92-2 Usage
Uses
Used in Pharmaceutical Industry:
CHEMBRDG-BB 4004130 is used as a potential anxiolytic and sedative-hypnotic agent for the treatment of anxiety and insomnia. Its mechanism of action involves modulation of the GABA neurotransmitter, which is crucial for the regulation of neuronal excitability and plays a significant role in the management of these conditions.
Used in Research and Development:
In the field of central nervous system pharmacology, CHEMBRDG-BB 4004130 is utilized as a subject of research to explore its specific mechanism of action and potential pharmacological effects. This research aims to enhance understanding of benzodiazepine compounds and their impact on neurological conditions, potentially leading to the development of novel therapeutic agents.
Used in Drug Design and Optimization:
CHEMBRDG-BB 4004130 serves as a valuable reference in the design and optimization of new drugs targeting the GABAergic system. By studying its structure-activity relationships and pharmacological profile, researchers can develop improved benzodiazepine-based drugs with enhanced efficacy and reduced side effects.
Used in Neurological Disorders Treatment:
Beyond anxiety and insomnia, CHEMBRDG-BB 4004130 may also be explored for its potential applications in the treatment of other neurological disorders that involve GABAergic dysregulation. This includes conditions such as epilepsy, certain types of chronic pain, and neurodegenerative diseases where modulation of GABAergic activity could provide therapeutic benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 30433-92-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,4,3 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 30433-92:
(7*3)+(6*0)+(5*4)+(4*3)+(3*3)+(2*9)+(1*2)=82
82 % 10 = 2
So 30433-92-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H11NS/c1-6-2-3-7(9-6)4-5-8/h2-3H,4-5,8H2,1H3
30433-92-2Relevant academic research and scientific papers
HETEROCYCLIC DERIVATIVES AS OREXIN ANTAGONISTS
-
Page/Page column 11-12, (2008/12/08)
The present invention relates to compounds of formula wherein R1, R2, R3, and R4 are as defined herein and hetaryl is a one or two ring-membered heteroaromatic ring system, connected to the carbon atoms of the p
INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS
-
Page 27, (2010/02/10)
The present invention relates to compounds of Formula I: I which are agonists of the M-1 muscarinic receptor.
